AGRX: Agile Therapeutics, Inc. - Summary | Jitta
Jitta Wealth
NEW
Log in
Sign up
×
Log in

Agile Therapeutics, Inc.

NASDAQ:AGRX

SummaryFactSheetFinancial
Notice
Stock data is unavailable or the company’s delisted.
Price
$1.51
Loss Chance
48.2%
2.68JITTA SCORE
99.50%Under Jitta Line
Jitta Ranking
Sorry, the data is not yet available for this stock.
HISTORICAL JITTA SCORE
Related
Amylyx Pharmaceuticals
NASDAQ:AMLX
1.66
$14.73
100.00%
Amphastar Pharmaceuticals
NASDAQ:AMPH
5.41
$19.00
72.47%
Collegium Pharmaceutical
NASDAQ:COLL
5.69
$37.80
89.12%
Corcept Therapeutics
NASDAQ:CORT
4.53
$52.28
350.10%
Dermira,
NASDAQ:DERM
0.97
$18.75
100.00%
Jitta Factors
Growth Opportunity (45)
Recent Business Performance (83)
Financial Strength (37)
Return to Shareholders (1)
Competitive Advantage (42)
Jitta Signs
Cash Conversion CycleLess than 30 days
Recent Business PerformanceEarning decline 102.15% in the last quarter (yoy)
CapExVery High
Key Stats
Jitta Score
Jitta Line
2.68
99.50%
3.12
94.96%
3.05
138.31%
Pharmaceuticals
1.66
100.00%
5.41
72.47%
5.69
89.12%
COMPANY DESCRIPTION
Agile Therapeutics, Inc., a women's healthcare company, researches, develops, and commercializes prescription contraceptive products for women in the United States. Its lead product is Twirla, also known as AG200-15, a once-weekly prescription combination hormonal contraceptive patch. The company is also developing a pipeline of Twirla line extensions and other products, including AG200-15 Extended Regimen (ER), a regimen that allows a woman to have four episodes of withdrawal bleeding per year; AG200-15 smaller patch (SmP), which is a regimen designed to provide shorter and lighter withdrawal bleeds, and enhance contraceptive efficacy; AG200-15 ER SmP, a regimen to allow a woman to extend the length of her contraceptive cycle, as well as have shorter and lighter withdrawal bleeding episodes per year; and P-Patch, a progestin-only contraceptive patch intended for use by women who are unable or unwilling to take estrogen. The company was incorporated in 1997 and is headquartered in Princeton, New Jersey.
www.agiletherapeutics.com
About UsCareersHelp CenterLibraryTermsPrivacyContact UsPress

Jitta Dot Com Co., Ltd. is the owner of the copyright of JITTA SCORE, JITTA LINE, JITTA SIGNS, JITTA FACTORS, JITTA LOSS CHANCE and JITTA RANKING. By accessing or using Jitta, you agree to comply with our Terms of Use and agree not to redistribute the information.

All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Any historical returns, backtest statistics or probability projections may not reflect future performance. Neither Jitta nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.

Fundamental data of companies, historical data, daily updates, financial statements, dividend data and index data are provided by S&P Global Market Intelligence. All stock prices are updated at the end of the day.